MapLight Therapeutics MPLT
NASDAQ MPLT
$9.67 -0.52 (-5.10%)
As of: Oct 1, 2026 · 3:55 PM EDT

MapLight Therapeutics (MPLT) Net Income (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported Net Income of -$61.2 million for Q2 2026, compared with -$29.98 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Net Income (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MapLight Therapeutics' Net Income came in at -$202.03 million; for FY2025, it came in at -$163.57 million.

  • By year, Net Income came in at -$78.44 million in FY2024.
  • Five-year quarterly Net Income spans a low of -$80.91 million in Q4 2025 and a high of -$19.81 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.51 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 MapLight Therapeutics 463.00 Mn 463.00 Mn - -61.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -61.20 Mn
Dec 31, 2025 -80.91 Mn
Sep 30, 2025 -29.95 Mn
Jun 30, 2025 -29.98 Mn
Dec 31, 2024 -21.88 Mn
Sep 30, 2024 -19.81 Mn
API Access

MapLight Therapeutics Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=MPLT&period=max&api_key=YOUR_API_KEY